SD Biosensor, Inc. (KRX:137310)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,500.00
+60.00 (0.71%)
At close: Apr 28, 2026
-8.60%
Market Cap 1.01T
Revenue (ttm) 710.58B
Net Income (ttm) -512.11B
Shares Out 118.62M
EPS (ttm) -4,279.00
PE Ratio n/a
Forward PE n/a
Dividend 200.00 (2.37%)
Ex-Dividend Date Mar 30, 2026
Volume 89,055
Average Volume 154,585
Open 8,420.00
Previous Close 8,440.00
Day's Range 8,400.00 - 8,540.00
52-Week Range 7,100.00 - 13,550.00
Beta 0.73
RSI 54.34
Earnings Date Feb 20, 2026

About SD Biosensor

SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides ST... [Read more]

Sector Healthcare
Founded 1999
Employees 576
Stock Exchange Korea Stock Exchange
Ticker Symbol 137310
Full Company Profile

Financial Performance

In 2025, SD Biosensor's revenue was 710.58 billion, an increase of 2.30% compared to the previous year's 694.57 billion. Losses were -512.11 billion, 420.4% more than in 2024.

Financial Statements

News

There is no news available yet.